Human EGFR Gene Mutation Detection Assay Kit

Molecular assay kit detecting EGFR gene mutations including EGFR-19del variant in tissue DNA and plasma cell-free DNA. Supports non-small cell lung cancer patient stratification and treatment selection.

This kit is used to in vitro qualitatively detect common mutations in exons 18-21 of the EGFR gene in samples from human non-small cell lung cancer patients.

PCR-based molecular diagnostic kit for detection of epidermal growth factor receptor mutations in solid tumors. Supports personalized cancer treatment planning and targeted therapy selection.

A reagent kit designed for the combined detection of human EGFR and ALK gene mutations. The kit is used for molecular testing to identify specific genetic mutations in patient samples.

A real-time PCR diagnostic kit for EGFR mutation detection. Used in solid tumour oncology for identifying epidermal growth factor receptor mutations in patient samples.

An in vitro diagnostic reagent kit for qualitative detection of EGFR and ALK gene mutations in non-small cell lung cancer (NSCLC). The kit has received Class III medical device registration certification from the National Medical Products Administration and is used for clinical diagnosis in hospitals nationwide.

In vitro diagnostic kit for detecting EGFR gene mutations in patient samples. Enables molecular profiling of epidermal growth factor receptor status to guide targeted cancer therapy selection and treatment planning in oncology.

A diagnostic kit based on GENETRON's proprietary 'one-step method' technology enabling completion of library construction in 1.5 to 3 hours (China patent ZL 201710218529.4). It detects EGFR, KRAS, BRAF, HER2, and PIK3CA gene mutations in DNA and ALK and ROS1 gene fusions in RNA from FFPE tissue samples of non-small cell lung cancer patients, as well as MET gene 14 exon skipping mutations.

Diagnostic kit for analyzing cancer-related genetic mutations and biomarkers. Provides genomic information to support targeted therapy selection and treatment planning.

Molecular diagnostic kit for cancer genomics profiling and tumor mutation analysis. Enables detection of somatic mutations relevant to oncology and cancer treatment planning.

In vitro diagnostic kit for detecting KRAS gene mutations in patient samples. Enables rapid molecular identification of KRAS mutations for oncology treatment planning and patient stratification. Supports precision medicine approaches in cancer care.

Kit for fast detection of actionable somatic FGFR3 mutations in solid tumors. Enables rapid identification of FGFR3 alterations for treatment decision-making.